Microglia in Alzheimer's Disease Neurodegeneration

📖 Wiki Page

cell639 wordssynced 2026-04-02

Microglia in Alzheimer's Disease Neurodegeneration

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Microglia in Alzheimer's Disease Neurodegeneration</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000129](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000129](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Immune surveillance</td>
<td>Detect pathogens, damage</td>
</tr>
<tr>
<td class="label">Synaptic pruning</td>
<td>Eliminate unnecessary synapses</td>
</tr>
<tr>
<td class="label">Support</td>
<td>Metabolic support for neurons</td>
</tr>
<tr>
<td class="label">Repair</td>
<td>Clear debris after injury</td>
</tr>
<tr>
<td class="label">Stage</td>
<td>Markers</td>
</tr>
<tr>
<td class="label">Stage 1</td>
<td>TREM2-independent</td>
</tr>
<tr>
<td class="label">Stage 2</td>
<td>TREM2-dependent</td>
</tr>
<tr>
<td class="label">Stage 3</td>
<td>Upregulated DAM genes</td>
</tr>
</table>

Overview

...

Microglia in Alzheimer's Disease Neurodegeneration

Overview

Microglia In Alzheimer'S Disease Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

[@colonna2016]

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

Morphology: microglial cell (source: Cell Ontology)
Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

Unknown (PanglaoDB):

External Database Links

[Cell Ontology (CL:0000129)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)
[OBO Foundry (CL:0000129)](http://purl.obolibrary.org/obo/CL_0000129)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

Unknown (PanglaoDB):

External Database Links

[Cell Ontology (CL:0000129)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)
[OBO Foundry (CL:0000129)](http://purl.obolibrary.org/obo/CL_0000129)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)

Introduction

Microglia In Alzheimer'S Disease Neurodegeneration is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Microglia are the resident immune cells of the central nervous system and play critical roles in Alzheimer's disease pathogenesis, representing both protective and harmful mechanisms.

Microglia Overview

CNS Distribution

Density: 10-15% of brain cells
Distribution: Uneven, higher in hippocampus
Surveillance: Constant process extension

Normal Functions

Dual Role in Alzheimer's Disease

Protective Functions

Amyloid clearance

Phagocytose Aβ plaques
Transport to periphery
Secretion of Aβ-degrading enzymes

Neuroprotection

Trophic factor release
Anti-inflammatory cytokine production
Maintenance of neuronal health

Harmful Functions

Chronic inflammation

Pro-inflammatory cytokine release
ROS/RNS production
Complement activation

Synaptic elimination

Excessive pruning
Contributing to cognitive decline
Complement-mediated damage

Microglial Activation States

Disease-Associated Microglia (DAM)

Progressive activation stages:

Key Receptors

TREM2: Critical for Aβ phagocytosis
CD33: Negative regulator of clearance
APOE: Lipid transport, microglial signaling

Neurodegenerative Mechanisms

1. Chronic Neuroinflammation

TNF-α, IL-1β, IL-6 elevation
Gliosis formation
Neuronal dysfunction

2. Synaptic Pruning

Complement C1q, C3 activation
Excessive synapse loss
Cognitive correlates

3. NLRP3 Inflammasome

ASC speck formation
IL-1β maturation
Pyroptosis induction

4. Tau Pathology Spread

[Microglia](/cell-types/microglia)mediated spread
Tau phosphorylation promotion

-NFT formation support

Therapeutic Targeting

Current Approaches

TREM2 agonists: Enhance clearance

Anti-inflammatory agents: Reduce harmful activation

CSF1R inhibitors: Deplete microglia (caution)

Complement inhibitors: Prevent synaptic loss

Emerging Strategies

Microglial replacement: Transplantation
Gene therapy: TREM2 modulation
Small molecule modulators: Selective targeting

Overview

Background

The study of Microglia In Alzheimer'S Disease Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Pathway Diagram

Mermaid diagram (expand to render)

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Phase-Separated Organelle Targeting](/hypothesis/h-ec731b7a) — 0.72 · Target: G3BP1
[Purinergic P2Y12 Inverse Agonist Therapy](/hypothesis/h-f99ce4ca) — 0.71 · Target: P2RY12
[Complement C1q Mimetic Decoy Therapy](/hypothesis/h-1fe4ba9b) — 0.71 · Target: C1QA
[Metabolic Circuit Breaker via Lipid Droplet Modulation](/hypothesis/h-3d993b5d) — 0.66 · Target: PLIN2
[Temporal Decoupling via Circadian Clock Reset](/hypothesis/h-019ad538) — 0.65 · Target: CLOCK
[Fractalkine Axis Amplification via CX3CR1 Positive Allosteric Modulators](/hypothesis/h-ba3a948a) — 0.63 · Target: CX3CR1
[Synthetic Biology Rewiring via Orthogonal Receptors](/hypothesis/h-e3506e5a) — 0.59 · Target: CNO
[Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics](/hypothesis/h-513a633f) — 0.58 · Target: ANXA1

Related Analyses:

[TREM2 agonism vs antagonism in DAM microglia](/analysis/SDA-2026-04-01-gap-001) 🔄
[Microglial subtypes in neurodegeneration — friend vs foe](/analysis/SDA-2026-04-02-gap-microglial-subtypes-20260402004119) 🔄
[TREM2 agonism vs antagonism in DAM microglia](/analysis/SDA-2026-04-02-gap-001) 🔄
[Microglia-astrocyte crosstalk amplification loops in neurodegeneration](/analysis/SDA-2026-04-01-gap-009) 🔄
[Synaptic pruning by microglia in early AD](/analysis/SDA-2026-04-01-gap-v2-691b42f1) 🔄

Pathway Diagram

The following diagram shows the key molecular relationships involving Microglia in Alzheimer's Disease Neurodegeneration discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →